Genetic susceptibility to pregnancy-related venous thromboembolism: Roles of factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations
- 1 November 1998
- journal article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 179 (5) , 1324-1328
- https://doi.org/10.1016/s0002-9378(98)70155-3
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Methylenetetrahydrofolate Reductase Polymorphism, Plasma Folate, Homocysteine, and Risk of Myocardial Infarction in US PhysiciansCirculation, 1996
- The factor V Leiden mutation may predispose women to severe preeclampsiaAmerican Journal of Obstetrics and Gynecology, 1996
- Increased fetal loss in women with heritable thrombophiliaThe Lancet, 1996
- Venous Thromboembolism during PregnancyNew England Journal of Medicine, 1996
- Hyperhomocysteinemia as a Risk Factor for Deep-Vein ThrombosisNew England Journal of Medicine, 1996
- Coexistence of Hereditary Homocystinuria and Factor V Leiden — Effect on ThrombosisNew England Journal of Medicine, 1996
- A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductaseNature Genetics, 1995
- Mutation in blood coagulation factor V associated with resistance to activated protein CNature, 1994
- Resistance to Activated Protein C as a Basis for Venous ThrombosisNew England Journal of Medicine, 1994
- Studies on Blood Coagulation and Fibrinolysis in Pregnancy, during Delivery and in the PuerperiumGynecologic and Obstetric Investigation, 1981